Emerging importance of tyrosine kinase inhibitors against cancer: quo vadis to cure? RK Mongre, CB Mishra, AK Shukla, A Prakash, S Jung, ... International Journal of Molecular Sciences 22 (21), 11659, 2021 | 24 | 2021 |
Assessing the current state of lung cancer chemoprevention: a comprehensive overview M Ashraf-Uz-Zaman, A Bhalerao, CM Mikelis, L Cucullo, NA German Cancers 12 (5), 1265, 2020 | 17 | 2020 |
Comparative pharmacological studies of Abelmoschuse sculentus Linn. Fruits and seeds SJ Shammi, R Islam, RM Ashraf-Uz-Zaman, B Alam Global Journal of Pharmacology 8 (1), 98-106, 2014 | 15 | 2014 |
Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity M Ashraf-Uz-Zaman, MS Sajib, L Cucullo, CM Mikelis, NA German Bioorganic & medicinal chemistry letters 28 (23-24), 3652-3657, 2018 | 10 | 2018 |
Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer M Ashraf-Uz-Zaman, S Shahi, R Akwii, MS Sajib, MJ Farshbaf, RR Kallem, ... European journal of medicinal chemistry 209, 112866, 2021 | 9 | 2021 |
Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus M Ashraf-Uz-Zaman, X Li, Y Yao, CB Mishra, BK Moku, Y Song Journal of Medicinal Chemistry 66 (15), 10746-10760, 2023 | 5 | 2023 |
In vivo evaluation of the pharmacological activities of Syzygium samarangense (Blume) Merr. & LM Perry, Adv R Majumder, NE Hasnat, MAU Zaman, MB Alam Biol. Res 8 (3), 107-115, 2014 | 5 | 2014 |
Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease M Ashraf-Uz-Zaman, TK Chua, X Li, Y Yao, BK Moku, CB Mishra, ... ACS Infectious Diseases 10 (2), 715-731, 2024 | 3 | 2024 |
Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis M Ashraf-Uz-Zaman, G Ji, D Tidwell, L Yin, S Thakolwiboon, J Pan, ... ACS chemical neuroscience 13 (2), 217-228, 2022 | 3 | 2022 |
Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target “mtFabH” of Mycobacterium tuberculosis N Kumar, RK Mongre, CB Mishra, R Srivastava, A Kumar, R Khatoon, ... Frontiers in Microbiology, 896, 2022 | 1 | 2022 |
Discovery, Structure–Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein–Protein Interactions between AF9/ENL and AF4 or DOT1L X Li, X Wu, S Nie, J Zhao, Y Yao, F Wu, CB Mishra, M Ashraf-Uz-Zaman, ... Cancers 15 (21), 5283, 2023 | | 2023 |
Discovery of novel compound promotes neurogenesis by activation of mTOR signaling M Ashraf-Uz-Zaman, B Vaidya, T Abbruscato, N German The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
Discovery and structure‐activity relationship study of novel series of mono‐amine transporter inhibitors for the treatment of neurodegenerative diseases M Ashraf-Uz-Zaman, G Ji, K Alvina, MS Sajib, C Mikelis, M Avila, ... The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
Novel diphenylbutylpiperidine analogs to treat lung cancer MAU Zaman, MS Sajib, C Mikelis, N German ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |
Selective Expression of 2-AG (2-Arachidonoyl Glycerol) Pathway in Mammary Gland Tissues. B Gudenkauf, K Gandhi, N German, AU Zaman, E Dick, ... REPRODUCTIVE SCIENCES 26, 342A-342A, 2019 | | 2019 |
Optimization of penfluridol for use in anticancer therapy MAU Zaman, MS Sajib, C Mikelis, N German ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | | 2018 |